Episode
Irritable Bowel Syndrome in 2026 Diagnosis, Investigation and Management for General Practice Dr Yanna Ko
- Published
- Aug 9, 2026
- Duration seconds
- 3701
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/general-practice-clinical-sessions-podcast-7705659/episodes/irritable-bowel-syndrome-in-2026-diagnosis-investigation-and-management-for-general-practice-dr-yanna-ko/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/general-practice-clinical-sessions-podcast-7705659/irritable-bowel-syndrome-in-2026-diagnosis-investigation-and-management-for-general-practice-dr-yanna-ko.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Irritable Bowel Syndrome in 2026: Diagnosing & Managing with Confidence Episode Summary: Are you still treating Irritable Bowel Syndrome (IBS) as a diagnosis of exclusion? In this episode, host Michelle Odayan sits down with gastroenterologist and PhD researcher Dr. Yanna Ko to discuss a transformative paradigm shift in general practice: making a confident, positive diagnosis of IBS. Together, they unpack the brand-new Rome 5 diagnostic criteria , outline essential investigations, and map out a practical, evidence-based step-up management plan to help your patients reclaim their quality of life. Key Takeaways for Your Clinical Practice: The Rome 5 Update: Learn why abdominal discomfort has been reincluded in the diagnostic criteria after a decade, and how updated frequency thresholds restore diagnostic sensitivity. The Power of a "Positive Diagnosis": Discover why moving away from a "diagnosis of exclusion" model reduces patient anxiety and prevents costly over-investigation. Targeted Investigations: Master the core panel of baseline tests (FBC, CRP, iron studies, coeliac serology and faecal calprotectin) that rule out organic disease with high accuracy. Identifying Red Flags: Confidently spot critical alarm features, such as nocturnal symptoms, rectal bleeding, weight loss, or high-risk family history of bowel cancer, that warrant immediate colonoscopy referrals. A Step-Up Management Algorithm: Get a clear roadmap of therapies based on severity and subtype, ranging from soluble fiber and the low-FODMAP diet to antispasmodics, neuromodulators, and gut-directed hypnotherapy. What to Avoid: Understand why international guidelines strongly advise against commercial microbiome mapping and breath testing for food intolerances in routine clinical practice. About Our Gues…